Skip to content

Clinical trials

Diabetes Mellitus, Type 2 trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Country / region: United States Clear all

3,223 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200019
200126
200233
200345
200478
200584
2006113
2007130
2008167
2009199
2010167
2011150
2012142
2013140
2014142
2015113
2016100
2017131
2018121
2019121
202094
2021167
2022146
2023142
2024141
2025137
2026137

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed2,353
Recruiting248
Terminated243
Active, not recruiting125
Unknown status99
Withdrawn82
Enrolling by invitation35
Not yet recruiting28
Suspended9
No longer available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S175
AstraZeneca167
Eli Lilly and Company141
GlaxoSmithKline78
Sanofi64
Pfizer62
Boehringer Ingelheim52
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)52
Hoffmann-La Roche43
University of Colorado, Denver41

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 23,223
Diabetes Mellitus736
Obesity390
Insulin Resistance195
Diabetes Mellitus, Type 1179
Hypertension121
Overweight117
Cardiovascular Diseases104
Prediabetic State89
Glucose Intolerance72

Trials

Showing 26 to 50 of 3,223. Each trial links to its page on Pharma Observatory.

3,123 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.